Nearly 30,000 people tested quit

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-10-09T11:27:29.030Z • Permanent link

Researchers from the University of Nottingham conducted a comprehensive review of 80 clinical trials, concluding that nicotine e-cigarettes are more effective in helping smokers quit than traditional methods such as patches, gum, and prescription medications. The findings, published in the Journal of the National Cancer Institute, involved nearly 30,000 participants worldwide. The study's lead author, Professor Ann McNeill, noted that e-cigarettes can be a valuable tool in quitting smoking, particularly for those who struggle with traditional methods. The research was funded by Cancer Research UK, a UK-based charity that has been supporting cancer research for over 100 years.

The review's methodology involved analyzing data from clinical trials conducted between 2010 and 2020, covering various e-cigarette products and nicotine delivery systems. The trials were conducted in several countries, including the UK, US, Australia, and Canada. The researchers found that e-cigarettes were more effective in helping smokers quit than traditional methods, with a higher success rate and lower rates of relapse. For example, a study published in the New England Journal of Medicine found that e-cigarettes were 50% more effective in helping smokers quit than traditional nicotine replacement therapy.

The review's findings have significant implications for public health policy and the development of new treatments for smoking cessation. Governments and health organizations around the world are likely to take notice of the research, particularly in light of the growing popularity of e-cigarettes among smokers. As e-cigarettes continue to evolve and improve, it is likely that they will play an increasingly important role in helping smokers quit. Professor McNeill emphasized the need for further research into the long-term effects of e-cigarettes, but the existing evidence suggests that they can be a valuable tool in quitting smoking.

The review's findings have significant implications for companies involved in the e-cigarette industry, including manufacturers and retailers. Companies such as British American Tobacco and Imperial Brands, which own e-cigarette brands such as Vuse and Glo, are likely to benefit from the research. The study's lead author, Professor McNeill, noted that the findings could lead to increased investment in e-cigarette research and development, potentially creating new opportunities for companies in the industry.

The review's findings also have implications for research communities and academic institutions. The study's methodology and results provide valuable insights into the effectiveness of e-cigarettes in helping smokers quit, and are likely to inform future research into the topic. The University of Nottingham, where the research was conducted, is a leading center for tobacco research and has a strong track record of producing high-quality research on smoking cessation.

The review's findings have significant implications for markets and policy environments, particularly in countries where e-cigarettes are heavily regulated. Governments around the world are likely to take notice of the research, particularly in light of the growing popularity of e-cigarettes among smokers. As e-cigarettes continue to evolve and improve, it is likely that they will play an increasingly important role in helping smokers quit, and governments will need to adapt their policies and regulations accordingly.